X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (367) 367
Publication (27) 27
Book / eBook (3) 3
Book Review (3) 3
Dissertation (2) 2
Book Chapter (1) 1
Conference Proceeding (1) 1
Patent (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (178) 178
oncology (172) 172
female (153) 153
breast cancer (101) 101
breast neoplasms - drug therapy (97) 97
index medicus (85) 85
breast neoplasms - pathology (73) 73
middle aged (66) 66
adult (56) 56
chemotherapy (56) 56
aged (51) 51
cancer (46) 46
antineoplastic combined chemotherapy protocols - therapeutic use (44) 44
therapy (40) 40
neoplasm staging (36) 36
treatment outcome (36) 36
chemotherapy, adjuvant (34) 34
breast neoplasms - therapy (31) 31
medicine & public health (30) 30
care and treatment (27) 27
tamoxifen (27) 27
hematology, oncology and palliative medicine (26) 26
antineoplastic agents - therapeutic use (23) 23
postmenopausal women (23) 23
survival (23) 23
women (23) 23
breast neoplasms - metabolism (22) 22
metastasis (22) 22
breast neoplasms - mortality (21) 21
clinical trials as topic (21) 21
prognosis (21) 21
disease-free survival (20) 20
trial (20) 20
antineoplastic agents, hormonal - therapeutic use (19) 19
antineoplastic combined chemotherapy protocols - adverse effects (19) 19
endocrine therapy (19) 19
male (19) 19
aromatase inhibitors (18) 18
clinical trials (18) 18
receptor, erbb-2 - metabolism (18) 18
trastuzumab (18) 18
antineoplastic agents - adverse effects (17) 17
capecitabine (17) 17
drug therapy (17) 17
neoplasm metastasis (17) 17
paclitaxel - administration & dosage (17) 17
aged, 80 and over (16) 16
breast neoplasms - surgery (16) 16
double-blind (16) 16
randomized-trial (16) 16
research (16) 16
survival analysis (15) 15
antineoplastic agents (14) 14
breast neoplasms - genetics (14) 14
combined modality therapy (14) 14
docetaxel (14) 14
drug administration schedule (14) 14
mastectomy (14) 14
risk factors (14) 14
surgical adjuvant breast (14) 14
adjuvant chemotherapy (13) 13
antimitotic agents (13) 13
article (13) 13
carcinoma (13) 13
medicine, general & internal (13) 13
randomized controlled trials as topic (13) 13
anastrozole (12) 12
breast-cancer (12) 12
first-line therapy (12) 12
metastatic breast cancer (12) 12
paclitaxel (12) 12
phase-iii trial (12) 12
receptor, erbb-2 - antagonists & inhibitors (12) 12
surgery (12) 12
1st-line treatment (11) 11
analysis (11) 11
breast neoplasms - diagnosis (11) 11
breast neoplasms - prevention & control (11) 11
cancer patients (11) 11
doxorubicin - administration & dosage (11) 11
health aspects (11) 11
kaplan-meier estimate (11) 11
letrozole (11) 11
open-label (11) 11
phase-iii (11) 11
postmenopause (11) 11
tamoxifen - therapeutic use (11) 11
taxoids - administration & dosage (11) 11
united states (11) 11
adjuvant therapy (10) 10
bevacizumab (10) 10
epidermal growth factor (10) 10
follow-up studies (10) 10
hematology (10) 10
neoadjuvant therapy (10) 10
pharmacology & pharmacy (10) 10
survival rate (10) 10
animals (9) 9
efficacy (9) 9
nccn clinical practice guidelines (9) 9
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Osteoporosis International, ISSN 0937-941X, 2/2016, Volume 27, Issue 2, pp. 499 - 507
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 09/2018, Volume 36, Issue 25, pp. 2621 - 2621
PurposeBevacizumab improves progression-free survival but not overall survival in patients with metastatic breast cancer. E5103 tested the effect of... 
NEOADJUVANT CHEMOTHERAPY | TRASTUZUMAB | ONCOLOGY | INDUCED PERIPHERAL NEUROPATHY | OPEN-LABEL | PACLITAXEL PLUS BEVACIZUMAB | DOSE-DENSE DOXORUBICIN | CONTAINING THERAPY | ENDOTHELIAL GROWTH-FACTOR | GENOME-WIDE ASSOCIATION | STAGE-II | ORIGINAL REPORTS
Journal Article
by Barker, C. A and Chang, M and Lassman, A. B and Beal, K and Chan, T. A and Hunter, K and Grisdale, K and Ritterhouse, M and Moustakas, A and Iwamoto, F. M and Kreisl, T. N and Sul, J and Kim, L and Butman, J and Albert, P and Fine, H. A and Chamberlain, M. C and Alexandru, D and Glantz, M. J and Bota, D. A and Takahashi, K and Ikeda, N and Kajimoto, Y and Miyatake, S and Kuroiwa, T and Iwamoto, F and Lamborn, K and Kuhn, J and Wen, P and Yung, W. K. A and Gilbert, M and Chang, S and Lieberman, F and Prados, M and Fine, H and Lu-Emerson, C and Norden, A. D and Drappatz, J and Quant, E. C and Ciampa, A. S and Doherty, L. M and LaFrankie, D. C and Wen, P. Y and Sherman, J. H and Moldovan, K and Yeoh, H. K and Starke, B. M and Pouratian, N and Shaffrey, M. E and Schiff, D and O'Connor, P. C and Kroon, H.-A and Recht, L and Montano, N and Cenci, T and Martini, M and D'Alessandris, Q. G and Banna, G. L and Maira, G and De Maria, R and Larocca, L. M and Pallini, R and Kim, C. H and Yang, M. S and Cheong, J. H and Kim, J. M and Shonka, N and Alfred Yung, W. K and Piao, Y and Liu, J and Bekele, N and Chen, A and Heymach, J and de Groot, J and Gilbert, M. R and Wang, M and Aldape, K and Sorensen, A. G and Mikkelsen, T and Bokstein, F and Woo, S. Y and Chmura, S. J and Choucair, A. K and Mehta, M and Perez Segura, P and Gil, M and Balana, C and Chacon, I and Munoz, J and Martin, M and Flowers, A and Salner, A and Gaziel, T. B and Soerensen, M and Hasselbalch, B and Poulsen, H. S and Lassen, U and Peyre, M and Cartalat-Carel, S and Meyronet, D and ... and on behalf of the ANOCEF Group and Roger Stupp on behalf of the EF-11 study investigators
Neuro-Oncology, ISSN 1522-8517, 10/2010, Volume 12, Issue Supplement 4, pp. iv36 - iv57
Journal Article
Expert Opinion on Pharmacotherapy, ISSN 1465-6566, 06/2006, Volume 7, Issue 8, pp. 1041 - 1053
Journal Article
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, ISSN 1540-1405, 05/2017, Volume 15, Issue 5.5, pp. 679 - 681
The management of advanced hormone receptor positive disease has evolved with the emergence of CDK4/6 inhibitors. Improvements in progression-free survival of... 
PALBOCICLIB | WOMEN | ONCOLOGY | LETROZOLE | INHIBITOR
Journal Article
Journal Article
by Prithviraj, G. K and Sommers, S. R and Jump, R. L and Halmos, B and Chambless, L. B and Parker, S. L and Hassam-Malani, L and McGirt, M. J and Thompson, R. C and Hunter, K and Chamberlain, M. C and Le, E. M and Lee, E. L. T and Sadighi, Z. S and Pearlman, M. L and Slopis, J. M and Vats, T. S and Khatua, S and DeVito, N. C and Yu, M and Chen, R and Pan, E and Cloughesy, T and Raizer, J and Drappatz, J and Gerena-Lewis, M and Rogerio, J and Yacoub, S and Desjardin, A and Groves, M. D and DeGroot, J and Loghin, M and Conrad, C. A and Hess, K and Ni, J and Ictech, S and Yung, W. A and Porter, A. B and Dueck, A. C and Karlin, N. J and Olson, J and Silber, J and Reiner, A. S and Panageas, K. S and Iwamoto, F. M and Cloughesy, T. F and Aldape, K. D and Rivera, A. L and Eichler, A. F and Louis, D. N and Paleologos, N. A and Fisher, B. J and Ashby, L. S and Cairncross, J. G and Roldan, G. B and Wen, P. Y and Ligon, K. L and Shiff, D and Robins, H. I and Rocque, B. G and Mason, W. P and Weaver, S. A and Green, R. M and Kamar, F. G and Abrey, L. E and DeAngelis, L. M and Jhanwar, S. C and Rosenblum, M. K and Lassman, A. B and Cachia, D and Alderson, L and Moser, R and Smith, T and Yunus, S and Saito, K and Mukasa, A and Narita, Y and Tabei, Y and Shinoura, N and Shibui, S and Saito, N and Flechl, B and Ackerl, M and Sax, C and Dieckmann, K and Crevenna, R and Widhalm, G and Preusser, M and Marosi, C and Ay, C and Dunkler, D and Pabinger, I and Zielinski, C and Belongia, M and Jogal, S and Schlingensiepen, K.-H and Bogdahn, U and Stockhammer, G and Mahapatra, A. K and Venkataramana, N. K and ...
Neuro-Oncology, ISSN 1522-8517, 11/2011, Volume 13, Issue suppl_3, pp. iii41 - iii68
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 10/2017, Volume 165, Issue 3, pp. 585 - 592
Journal Article
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, ISSN 1540-1405, 05/2016, Volume 14, Issue 5.5, pp. 641 - 644
The updates to management of early invasive breast cancer in 2016 are minor but have important treatment implications for patients. The NCCN Guidelines Panel... 
IRRADIATION | PALBOCICLIB | MULTICENTER | TRASTUZUMAB | ONCOLOGY | OPEN-LABEL
Journal Article
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, ISSN 1540-1405, 05/2014, Volume 12, Issue 5.5, pp. 759 - 761
Many newer agents in combination are being studied in the front-line treatment of women with HER2-positive metastatic breast cancer (MBC), but the story in the... 
TRIAL | PLACEBO | EXEMESTANE | ONCOLOGY | FULVESTRANT | COMBINATION | AROMATASE INHIBITORS | ANASTROZOLE
Journal Article
Journal Article
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, ISSN 1540-1405, 07/2013, Volume 11, Issue 7, pp. 753 - 761
These NCCN Guidelines Insights highlight the important updates specific to the management of HER2-positive metastatic breast cancer in the 2013 version of the... 
TRASTUZUMAB PLUS DOCETAXEL | TRIAL | CLEOPATRA | ONCOLOGY | PERTUZUMAB | TOLERABILITY | Recurrence | Neoplasm Metastasis | Humans | Receptor, ErbB-2 - metabolism | Female | Breast Neoplasms - diagnosis | Receptor, ErbB-2 - antagonists & inhibitors | Molecular Targeted Therapy | Neoplasm Staging | Breast Neoplasms - drug therapy
Journal Article
Journal Article